Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Net Cash Flow: 2015-2025

Historic Net Cash Flow for AC Immune (ACIU) over the last 10 years, with Sep 2025 value amounting to -$9.3 million.

  • AC Immune's Net Cash Flow rose 50.74% to -$9.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$16.6 million, marking a year-over-year decrease of 410.58%. This contributed to the annual value of -$46.3 million for FY2024, which is 185.46% down from last year.
  • AC Immune's Net Cash Flow amounted to -$9.3 million in Q3 2025, which was down 203.85% from $9.0 million recorded in Q2 2025.
  • AC Immune's 5-year Net Cash Flow high stood at $54.0 million for Q4 2023, and its period low was -$51.2 million during Q2 2021.
  • For the 3-year period, AC Immune's Net Cash Flow averaged around -$1.1 million, with its median value being -$9.3 million (2025).
  • As far as peak fluctuations go, AC Immune's Net Cash Flow slumped by 1,408.62% in 2021, and later surged by 513.24% in 2023.
  • Quarterly analysis of 5 years shows AC Immune's Net Cash Flow stood at -$11.7 million in 2021, then dropped by 11.48% to -$13.1 million in 2022, then surged by 513.24% to $54.0 million in 2023, then slumped by 95.96% to $2.2 million in 2024, then soared by 50.74% to -$9.3 million in 2025.
  • Its Net Cash Flow stands at -$9.3 million for Q3 2025, versus $9.0 million for Q2 2025 and -$18.5 million for Q1 2025.